Clinical Trials List
Protocol NumberALKS 2680‑302
Not yet recruiting
2026-05-01 - 2027-07-28
Phase III
Recruiting3
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/06/01
Investigators and Locations
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
3-4 participants
-
Global
138 participants
